Ra Capital Management, L.P. Cullinan Oncology, Inc. Transaction History
Ra Capital Management, L.P.
- $61.3 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding CGEM
# of Institutions
118Shares Held
42.8MCall Options Held
12.6KPut Options Held
4.9K-
Bio Impact Capital LLC Cambridge, MA7.65MShares$133 Million21.33% of portfolio
-
Chi Advisors LLC New York, NY3.41MShares$59.5 Million15.23% of portfolio
-
Bvf Inc San Francisco, CA3.2MShares$55.8 Million1.63% of portfolio
-
Blue Owl Capital Holdings LP New York, NY2.92MShares$51 Million13.21% of portfolio
-
Franklin Resources Inc San Mateo, CA2.7MShares$47 Million0.02% of portfolio
About Cullinan Oncology, Inc.
- Ticker CGEM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,612,200
- Market Cap $795M
- Description
- Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...